Related Experiment Video
Updated: Apr 12, 2026

'Bioluminescent' Reporter Phage for the Detection of Category A Bacterial Pathogens
Published on: July 8, 2011
[Human plague and pneumonic plague : pathogenicity, epidemiology, clinical presentations and therapy]
Julia M Riehm1, Thomas Löscher
1Zentrales Institut des Sanitätsdienstes der Bundeswehr, Ingolstädter Landstr. 102, 85748, München, Deutschland, juliariehm@bundeswehr.org.
Abstract:
Yersinia pestis is a highly pathogenic gram-negative bacterium and the causative agent of human plague. In the last 1500 years and during three dreaded pandemics, millions of people became victims of Justinian's plague, the Black Death, or modern plague. Today, Y. pestis is endemic in natural foci of Asian, African and American countries. Due to its broad dissemination in mammal species and fleas, eradication of the pathogen will not be possible in the near future. In fact, plague is currently classified as a "re-emerging disease". Infection may occur after the bite of an infected flea, but also after oral ingestion or inhalation of the pathogen. The clinical presentations comprise the bubonic and pneumonic form, septicemia, rarely pharyngitis, and meningitis. Most human cases can successfully be treated with antibiotics. However, the high transmission rate and lethality of pneumonic plague require international and mandatory case notification and quarantine of patients. Rapid diagnosis, therapy and barrier nursing are not only crucial for the individual patient but also for the prevention of further spread of the pathogen or of epidemics. Therefore, WHO emergency schedules demand the isolation of cases, identification and surveillance of contacts as well as control of zoonotic reservoir animals and vectors. These sanctions and effective antibiotic treatment usually allow a rapid containment of outbreaks. However, multiple antibiotic resistant strains of Y. pestis have been isolated from patients in the past. So far, no outbreaks with such strains have been reported.
Insights
Yersinia pestis causes plague, a re-emerging disease endemic globally. While treatable with antibiotics, pneumonic plague requires strict public health measures to prevent epidemics, especially with emerging antibiotic resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Yersinia pestis is a highly pathogenic bacterium responsible for human plague.
- Plague has caused millions of deaths throughout history via three major pandemics.
- The pathogen remains endemic in various countries, affecting mammal species and fleas, making eradication unlikely.
Purpose of the Study:
- To provide an overview of Yersinia pestis, its transmission, clinical manifestations, and public health implications.
- To highlight the importance of rapid diagnosis, treatment, and control measures for plague.
- To address the threat of antibiotic-resistant Yersinia pestis strains.
Main Methods:
- Review of historical and current epidemiological data on plague.
- Description of Yersinia pestis transmission routes and clinical presentations.
- Discussion of public health strategies for plague containment and surveillance.
Main Results:
- Yersinia pestis infection can occur through flea bites, ingestion, or inhalation, leading to bubonic, pneumonic, or septicemic forms.
- Most human plague cases are treatable with antibiotics, but pneumonic plague poses a high risk of transmission and mortality.
- While antibiotic-resistant strains have been identified, no large outbreaks have been reported to date.
Conclusions:
- Plague is a re-emerging infectious disease requiring continuous surveillance and control efforts.
- Effective management relies on prompt diagnosis, antibiotic therapy, isolation of patients, contact tracing, and vector control.
- The potential emergence of antibiotic-resistant Yersinia pestis necessitates ongoing vigilance and research.
Related Concept Videos
Pneumonia II: Pathophysiology
Atypical Pneumonia
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Infectious Diseases and Their Occurrence
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

